Rapid Reduction in Donor-Specific Anti-Human Leukocyte Antigen Antibodies and Reversal of Antibody-Mediated Rejection With Bortezomib in Pediatric Heart Transplant Patients

BACKGROUND: High titer donor-specific antibodies (DSA) and positive crossmatch in cardiac transplant recipients is associated with increased mortality from antibody-mediated rejection (AMR). Although treatment to reduce antihuman leukocyte antigen antibodies using plasmapheresis, intravenous immunog...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Morrow, William Robert, Frazier, Elizabeth A., Mahle, William T., Harville, Terry O., Pye, Sherry E., Knecht, Kenneth R., Howard, Emily L., Smith, R. Neal, Saylors, Robert L., Garcia, Xiomara, Jaquiss, Robert D.B., Woodle, E. Steve
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3730122/
https://ncbi.nlm.nih.gov/pubmed/22179403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0b013e31823f7eea
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky